The American Proficiency Institute (API) has developed one of the world’s first proficiency testing programs for SARS-CoV-2, the virus at the root of the coronavirus infectious disease pandemic (COVID-19). This proficiency testing program provides laboratories with an objective means for assessing their performance in testing for COVID-19.
“We are engaged in a great war with a novel virus,” explained Daniel C. Edson, API President. “It is our hope that by using this proficiency testing program for SARS-CoV-2, external quality control measures will be in place for all clinical laboratories worldwide.”
Proficiency testing utilizes reference materials that mimic the SARS-CoV-2 virus but are actually safe and non-infectious. Clinical laboratories interested in enrolling in the program may reach out to API directly: https://www.api-pt.com/catalog.aspx.
The American Proficiency Institute is one of the largest proficiency testing providers in the world, serving over 20,000 laboratories. API offers innovative solutions and technical excellence for the proficiency testing needs of hospital and reference laboratories, physician offices, clinics and point-of-care testing sites.
